| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |